Growth Opportunities and Trends in the Controlled Substance Market: Key Insights for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the controlled substance market grown in recent years?
In recent times, the market size for controlled substances has seen significant growth. A rise from $94.86 billion in 2024 to $101.15 billion in 2025 is projected, corresponding to a compound annual growth rate (CAGR) of 6.6%. This progression during the historical period can be connected to advancements in healthcare, regulatory infrastructures, an increased prevalence of chronic illness, growth of the pharmaceutical industry, global commerce, and collaboration.
How is the controlled substance market size expected to evolve during the forecast period?
Predictions indicate booming expansions in the controlled substance market in the coming years, with projections reaching up to $136.51 billion by 2029, reflecting a compound annual growth rate (CAGR) of 7.8%. This surge in the forecast period can be linked to several factors such as the rise of precision medicine, telemedicine and remote healthcare, the emergence of alternatives to opioids, ongoing regulatory updates, and the increasing focus on mental health. The forecast period also reveals significant trends like regulatory shifts and compliance, growing emphasis on drug safety and abuse prevention, advances in drug delivery technologies, the advent of biosimilars and generic versions, and the inclusion of digital health solutions.
Get your controlled substance market report here!
https://www.thebusinessresearchcompany.com/report/controlled-substance-global-market-report
Which key drivers are propelling the controlled substance market’s growth?
The surging need for drugs prescribed by medical professionals is anticipated to fuel the expansion of the controlled substance market in the near future. Prescription medication generally pertains to drugs utilized for disease treatment, cure, amendment, therapeutic intervention, or prevention. They are often classified under controlled substances. These prescribed medications prove advantageous to the controlled substance market as they can improve patient results while reducing unnecessary expenditure. For instance, as per a September 2024 report presented by the Centers for Medicare and Medicaid Services (CMS), a federal agency based out of the US, there was an 8.4% increase, amounting to $405.9 billion, in prescription drug expenditure in 2022, compared to the 6.8% rise seen in 2021. Consequently, the escalating demand for prescribed medication is steering the growth of the controlled substance market.
What are the market segments in the controlled substance industry?
The controlled substance market covered in this report is segmented –
1) By Drug: Opioids, Stimulant, Depressants, Cannabinoids
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Pain Management, Sleep Disorders, Depression And Anxiety, Seizure, Attention Deficit Hyperactivity Disorder (ADHD), Other Applications
Subsegments:
1) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids
2) By Stimulants: Amphetamines, Methylphenidate, Cocaine
3) By Depressants: Benzodiazepines, Barbiturates, Sleep Medications
4) By Cannabinoids: THC (Tetrahydrocannabinol), CBD (Cannabidiol), Synthetic Cannabinoids
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9898&type=smp
Which leading companies are shaping the growth of the controlled substance market?
Major companies operating in the controlled substance market include Merck & Co. Inc., Johnson and Johnson Services Inc., Orbis Biosciences Inc., GW Pharmaceuticals plc, Corium Inc., Aradigm Corporation, Alkermes plc, Sun Pharmaceutical Ltd., F. Hoffmann-La Roche Ltd., AbbVie Inc., Ampac Fine Chemicals, Siegfried Holding AG, Pfizer Inc., Novartis AG, GlaxoSmithKline plc, Sanofi S.A., Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Teva Pharmaceutical Industries, Viatris Inc., Boehringer Ingelheim, Gilead Sciences, Amgen, Regeneron Pharmaceuticals, Abbott Laboratories, Mallinckrodt Pharmaceuticals, Endo International, Catalent, Cambrex Corporation, Lonza Group, Indivior plc, Ipsen SA
What key trends are currently impacting the controlled substance market’s development?
Trend 1 mentions that product innovations are the leading trend in the controlled substance market, with major corporations introducing new drugs and products to solidify their market presence. In a notable event in January 2022, UK’s CareFlow Medicines Management Ltd. (CMM) teamed up with Modeus, an Australian health software company, to launch their Controlled Drug Manager (CD Manager). This advanced platform for controlled drug management was created to safely control and monitor controlled substances, including patient’s own medicines. The newly introduced CMM CD Manager, driven by Modeus, can function seamlessly with CMM’s medication management platform and other external systems. It is specifically designed for application by clinical staff and pharmacists within hospital pharmacies, wards, and operation theatres where controlled medications are housed. The built-in reporting feature in the CD Manager aids Controlled Drug Accountable Officers in monitoring controlled drugs life cycle within an institution and enables them to take swift action on any discrepancies or possible diversion warnings.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9898
Which geographic areas are influencing the growth of the controlled substance market?
North America was the largest region in the controlled substance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the controlled substance market report during the forecast period. The regions covered in the controlled substance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Fructose Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/fructose-global-market-report
Stevia Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/stevia-global-market-report
Sugar And Confectionery Products Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
